Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Replimune Inc.
Replimune Inc.
Bristol-Myers Squibb
University of California, San Diego
Tesaro, Inc.
Genelux Corporation
Bristol-Myers Squibb
DEKA Biosciences
Celgene
Compugen Ltd
Eli Lilly and Company
Case Comprehensive Cancer Center
Oslo University Hospital
Apexigen America, Inc.
Bristol-Myers Squibb
Genocea Biosciences, Inc.
Ardigen
Ardigen
AbbVie
AbbVie
Dynavax Technologies Corporation
Bristol-Myers Squibb